250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 50 Medical VC Funds in Germany

A list of 50 VC funds that invest in Medical startups based in Germany. We rank investors based on the number of investments they made in Medical companies from Germany. We update this investor list every month.

Top 50 Medical VC Funds in Germany

Investor Medical Germany investments
HTGF | High-Tech Gruenderfonds 15
Bayern Kapital 13
KfW 12
NRW.BANK 7
Wellington Partners 7
MIG Capital 7
b2venture (formerly btov Partners) 6
BioMedPartners 6
TGFS - Technologiegründerfonds Sachsen 5
Calm/Storm Ventures 5
bm-t beteiligungsmanagement thuringen 5
Picus Capital 5
Possible Ventures 5
IBB Ventures 5
HV Capital 5
Atlantic Labs 4
Brandenburg Kapital 4
EQT Life Sciences 4
seed + speed Ventures 4
Rheingau Founders 4
WestTech Ventures 3
BayBG Venture Capital 3
DvH Ventures 3
Vorwerk Ventures 3
Sparkasse Jena 3
Playground Global 3
Global Asset Fund 3
Boehringer Ingelheim Venture Fund 3
Forbion Capital Partners 3
Vesalius Biocapital Partners 3
Born2Grow 3
MBG Baden Wuerttemberg 2
Enjoyventure Management 2
SV Investment Corp 2
WEGVISOR 2
Andera Partners 2
HBM Healthcare Investments AG 2
Aescuvest 2
Global Founders Capital 2
Initiative for Industrial Innovators 2
Antler 2
SHS Capital 2
Project A Ventures 2
European Investment Bank 2
German Federal Ministry of Education and Research (BMBF) 2
Green Park & Golf Ventures 2
Global Life Science Ventures 2
Loric Ventures 2
KHAN Technology Transfer Fund 2
Saarbruecker 21 2
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
HTGF | High-Tech Gruenderfonds VC Fund · Bonn, Nordrhein-Westfalen, Germany · 55 investments in the past 12 months
The seed investor High-Tech Gründerfonds (HTGF) finances tech start-ups with growth potential and has supported more than 700 start-ups since 2005. With the launch of its fourth fund, HTGF now has about 1.4 billion euros under management. Its team of experienced investment managers and start-up experts support young companies with expertise,entrepreneurial spirit and passion. HTGF’s focus is on high-tech start-ups in the fields of digital tech, industrial tech, life sciences, chemistry and related business areas. To date, external investors have injected about 5 billion euros of capital into the HTGF portfolio via more than 2,000 follow-on financing rounds. In addition, HTGF has already successfully sold shares in more than 170 companies. Fund investors in this public-private partnership include the German Federal Ministry for Economic Affairs and Climate Action, KfW Capital and 45 companies from a wide range of industries. Fund investors in this public-private partnership include the German Federal Ministry for Economic Affairs and Climate Action, KfW Capital and 45 companies from a wide range of industries.
Show more
Investment focus
  • Software, Information Technology, Biotechnology
  • Seed, Series A, Funding Round
  • Germany, Switzerland, United States
Portfolio highlights
  • Graswald — Graswald engages in the creation of natural and digital 3D worlds for the entertainment industry.
  • Scavenger AI — Generative AI and Data Analytics for your daily business challenges. Scavenger uses Artificial Intelligence and Machine Learning Algorithms to power its 3 tools: Purity, Quantum and Prophecy. Purity cleans and harmonizes the data. Quantum runs statistical algorithms and analyzes the data. Prophecy d
  • CustomSurg — RETHINKING TRAUMA SURGERY At CustomSurg we are changing the treatment of complex bone fractures from a subjective to an objective approach, through personalized solutions.
Bayern Kapital VC Fund · Landshut, Bayern, Germany · 22 investments in the past 12 months
Bayern Kapital (founded at the end of 1995) is a wholly owned subsidiary of the LfA Foerderbank Bayern (Bavaria‘s development bank). Bayern Kapital’s objective is to finance research and development as well as the market launch of new products, product diversifications, and expansion of the market share.The requesting company has to be located inBavaria. Industries are e. g. IT/software, life sciences, new materials, micro-systems and environmental technologies.Bayern Kapital and its funds have invested in more than 250 companies and currently manages funds to the value of EUR 340 m. The five investing funds currently managed by Bayern Kapital are Seedfonds Bayern, Clusterfonds Start-Up!, Innovationsfonds, Innovationsfonds EFRE and Wachstumsfonds Bayern.
Show more
Investment focus
  • Software, Health Care, Information Technology
  • Seed, Series A, Funding Round
  • Germany, United States, Finland
Portfolio highlights
  • VITAS — Our system is based on Deep Learning and offers an intelligent voice assistant for customer service. Use cases can be found in both the SME and enterprise market for all companies with many standardized customer calls. VITAS answers the telephone, checks data in real time, can react flexibly to requests and offers the caller a self-service withoutwaiting time. Areas of application include restaurants, workshops, medical practices, taxi centres, insurance companies, banks and tax consultants.
  • BOX ID Systems — BOX ID Systems develops and offers an end-to-end location & process mining solution to cost effectively track millions of logistics assets digitally throughout the industrial supply chain across Europe and the World - including site-to-site, on-premises and indoor buildings digital twin of supply chain processes. The system is built on aspecialized analytics software platform, sensorik tracking devices and efficient data-, device- and user-management tools, including functions to support process automation and optimization. Industrial and automotive production customers benefit from making their logistics processes more efficient and cost optimized, with 100% transparency within their critical processes throughout the entire supply chain.
  • Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and
KfW VC Fund · Frankfurt, Hessen, Germany
KfW gives impetus to economic, social and ecological development worldwide. As a promotional bank under the ownership of the Federal Republic and the Länder (federal states), it offers support to encourage sustainable improvement in economic, social, ecological living and business conditions, among others in the areas of small and medium-sizedenterprise, entrepreneurialship, environmental protection, housing, infrastructure, education finance, project and export finance, and development cooperation.
Show more
Investment focus
  • Biotechnology, Software, Health Care
  • Funding Round, Series A, Series B
  • Germany, India, Kenya
Portfolio highlights
  • Uniper — Uniper is an international energy company with about 11,000 employees. They combine a balanced portfolio of technologically advanced large-scale assets with outstanding technical and commercial expertise. Uniper is a German energy company based in Dusseldorf, North Rhine-Westphalia. It was formed by the separation of E.ON's fossil fuel assetsinto a separate company that began operating on 1 January 2016.
  • Vectoflow — Vectoflow is an innovative company developing fluid-dynamic metrology devices for fluid flow and dynamics measurement. It offers standardized and customized flow measurement technology that measures the static and total pressure, velocity, and angle of attack of a flow. These products are used in motorsport, aviation, turbine machine development,and research sectors.
  • Electrochaea — Electrochaea is commercializing a disruptive, scalable technology to convert electric power into methane, the principal component of natural gas. Using CO2 as a feedstock gas, power can be efficiently converted to renewable natural gas for power storage, for transportation fuels, or for transmission via a natural gas network. The company licensedtechnology from the University of Chicago and is led by the Nidus Partners, a St. Louis investment group specializing in renewable energy. Mich Hein, a Nidus Managing Partner, serves as CEO.Electrochaea has developed a commercially viable and disruptive solution for utility-scale energy storage, grid balancing, and carbon reuse. Their proprietary process converts low-cost and stranded electricity and carbon dioxide into pipeline-grade renewable gas for direct injection into the existing natural gas grid, a conversion process known as “power-to-gas”.
NRW.BANK VC Fund · Düsseldorf, Nordrhein-Westfalen, Germany · 4 investments in the past 12 months
NRW.BANK is the development bank for the state of North Rhine-Westphalia. It supports its owner – the state of North Rhine-Westphalia – in fulfilling its tasks, notably in the fields of structural, economic, social and housing policy. NRW.BANK pools the promotion and development programmes of the state of North Rhine-Westphalia, the FederalRepublic of Germany and the European Union and combines them with its own equity and debt products and advisory services. It offers the full range of financial products in three areas “Economy”, “Housing”, and “Infrastructure/Municipalities”. NRW.BANK operates in a competitively neutral manner as a partner of banks and savings banks.
Show more
Investment focus
  • Biotechnology, Software, Information Technology
  • Seed, Series A, Series B
  • Germany, United States, United Kingdom
Portfolio highlights
  • widu — widu enables real estate and accommodation companies to source visuals (photography, video, drone) at scale through its serviced marketplace
  • Companyon Analytics — Companyon Analytics provides data security, cloud infrastructure, information technology, technical solutions, and consultancy services.
  • Prothea Technologies — Prothea Technologies is a private medical technology business to provide lung cancer biopsy and therapy in a single hospital visit.
Wellington Partners VC Fund · Munich, Bayern, Germany
Wellington Partners is a venture capital firm that invests in technology and life sciences companies, focusing on Digital Media, Software, Electronics & Photonics, Resource Efficiency, and Biotech/Life Sciences. It is committed to providing outstanding entrepreneurs with the necessary resources to fund their strategies. We typically leadfinancing rounds ranging from € 0.5 million to € 20 million. Depending on the maturity of the company, its own commitment can go as high as € 15 million.Wellington was established in 1998 and has offices in Munich, London, and Zurich.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series A, Series B, Funding Round
  • Germany, United States, United Kingdom
Portfolio highlights
  • Nosto — Smarter commerce experience management with AI-fueled personalization, merchandising, and site search
  • Minervax — MinervaX is pursuing the development of a vaccine against Group B streptococcus (GBS) infections by utilizing a particular fusion protein : click to read more
  • Seamless Therapeutics — Seamless Therapeutics is changing the paradigm of gene editing through a pioneering approach to restore health in patients with severe conditions in a safe and precise manner. Seamless technology platform unlocks the reprogramming of recombinases, a highly versatile class of enzymes.
MIG Capital VC Fund · München, Bayern, Germany · 2 investments in the past 12 months
Zusammen gestalten wir die Unternehmen von morgen.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Funding Round, Series B
  • Germany, France, Austria
Portfolio highlights
  • AMSilk — AMSilk produces and distributes high-quality silk biopolymers for use in textile products, medical devices, and cosmetics.
  • HawkCell — A plug-and-play solution turning human MRI into the first animal-dedicated imaging enhanced with AI algorithms. A unique MRI solution.
  • Look Up Space — Lookup space is the next global leader for space safety, security and sustainability
b2venture (formerly btov Partners) VC Fund · Saint Gallen, Sankt Gallen, Switzerland · 11 investments in the past 12 months
B2venture is a venture capital firm focused on early-stage investments in digital and industrial technology companies. B2venture invests EUR 100m+ per year in high-growth companies with ticket sizes from EUR 0.25m to 3.5m.
Show more
Investment focus
  • Software, Health Care, Information Technology
  • Series A, Seed, Series B
  • Germany, Switzerland, United Kingdom
Portfolio highlights
  • Yendou — We make it unbelievably easy, for clinical operations teams, to manage site selection activities for oncology clinical trials.
  • DUDE CHEM — DUDE CHEM is a leading company in green chemical manufacturing based in Berlin.
  • Aeovian Pharmaceuticals — Aeovian is a San Francisco based biopharmaceutical company developing novel and highly selective therapeutics modulating mTORC1 pathway.
BioMedPartners VC Fund · Basel, Basel-Stadt, Switzerland
BioMedPartners is one of the leading European venture capital firms providing private equity and mezzanine financing to early- and mid-stage healthcare and human life science companies. They target the entire industry with special focus on pharmaceuticals, biotechnology, diagnostics and medical technology.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • Switzerland, Germany, France
Portfolio highlights
  • Tricares — TRiCares is a medical device company, devoted to developing a catheter-based valve replacement system for minimal invasive treatment of tricuspid valve regurgitation.
  • ImmunOs Therapeutics — ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.
  • Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and
TGFS - Technologiegründerfonds Sachsen VC Fund · Leipzig, Sachsen, Germany · 5 investments in the past 12 months
TGFS - Technologiegruenderfonds Sachsen is an early stage VC fund targeting high tech startups with strong growth potential. The fund invests into ventures located in Saxony/Germany, Europe's leading semiconductor cluster. The team has invested into more than 120 companies so far, including more than 40 investments from the currentfund.
Show more
Investment focus
  • Software, Information Technology, Manufacturing
  • Seed, Funding Round, Series A
  • Germany, United States
Portfolio highlights
  • MiViA — From microstructure segmentation to grain size measurement! Our AI engine provides a fast and reliable metallographic analysis for metallic products.}
  • watttron — Watttron invents a revolutionary heating system that can heat up surfaces heterogeneously.Watttron develops an innovative heating technology that can be used in various industrial processes. It is superior to current heating systems in many ways and offers a number of advantages. On the following pages, you will find information about possibleapplications and opportunities.The company is located in the Technologie- und Gründerzentrum Freital – a technology and start-up center on the outskirts of Dresden, the state capital of Saxony.
  • volytica diagnostics — Our battery monitoring software reduces operational risks from e-mobility to storage and enhances battery life.
Calm/Storm Ventures VC Fund · Vienna, Wien, Austria · 13 investments in the past 12 months
Calm/Storm is an exclusive founder network and venture capital firm. We invest in purpose driven founders changing our life & health for the better. Headquartered in Vienna, Austria we invest in early-stage companies all over Europe and the US. We focus on the pre-seed and seed stages but also invest up to Series A.
Show more
Investment focus
  • Health Care, Wellness, Software
  • Seed, Pre-Seed, Series A
  • Germany, United Kingdom, Austria
Portfolio highlights
  • Scavenger AI — Generative AI and Data Analytics for your daily business challenges. Scavenger uses Artificial Intelligence and Machine Learning Algorithms to power its 3 tools: Purity, Quantum and Prophecy. Purity cleans and harmonizes the data. Quantum runs statistical algorithms and analyzes the data. Prophecy d
  • ThinkSono — ThinkSono is a company at the cutting edge of medicine and technology.
  • Foundation Health — Foundation Health is a telehealth and nationwide pharmacies and diagnostic distribution centre
bm-t beteiligungsmanagement thuringen VC Fund · Erfurt, Thuringen, Germany
bm|t supports innovative and growth-oriented companies in Thuringia with equity investments and venture capital.
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Seed, Funding Round, Series A
  • Germany, United States
Portfolio highlights
  • rooom.com — rooom is a global startup based in Germany, launched in 2019. The company’s experienceCloud is an all-in-one platform for creating, managing and promoting engaging 2D, 3D, AR & VR experiences. It works across all desktop and mobile devices. rooom’s experienceCloud is designed to cover the marketing and visualization needs of differentindustries through their comprehensive product portfolio. These include eventCloud (optimized for virtual events, exhibitions, conferences, meetings), spaceCloud (real estate, property, museums), productCloud (3D products, product showrooms) and immerseCloud (tours, guides, 3D books). rooom’s eventCloud is routinely hosting up to 200,000 users for hybrid events like IFA, Berlin and for global customers such as Porsche, Deutsche Telekom, DHL and E.ON. rooom has won over 20 awards, including the Global Eventex Award (twice), the Innovation & Excellence Award and the German Innovation Award.
  • tediro — tediro develops a mobile robotics platform for multiple applications in healthcare primarily therapy and diagnostics
  • Coachwhisperer — Coachwhisperer: The live communication system for sports. We take training to the next level and help coaches and athletes reach their true potential.
Picus Capital VC Fund · Munich, Bayern, Germany · 13 investments in the past 12 months
Picus Capital is an early-stage technology investment firm with a long-term investment philosophy. We work together with daring technology companies to build successful, global companies challenging the status quo and shaping tomorrow.
Show more
Investment focus
  • Financial Services, FinTech, Software
  • Seed, Series A, Pre-Seed
  • Germany, United States, United Kingdom
Portfolio highlights
  • Silverflow — Silverflow offers global payment technology to power financial institutions.
  • Niko Energy — Niko is a Mexico-based provider of residential solar electricity and solar power services for homeowners. It is the first solar company in the country offering rent-to-own financing products on top leasing and cash payments. Fully focused on customer experience, Niko provides a 5-star journey owning each step of the value chain in-house, ensuringquality, security and peace of mind for its customers.
  • Baselayer — Baselayer automates business risk assessment and eliminates B2B fraud in the financial sector. It offers services such as business verification (KYB), fraud detection, business onboarding optimization, risk profiling, portfolio monitoring & alerting, and workflow automation. Baselayer empowers 100s of financial institutions, governmentagencies, lenders, and fintech to unlock instant trust with any business in America.
Possible Ventures VC Fund · Munich, Bayern, Germany · 16 investments in the past 12 months
Possible Ventures backs ambitious teams building frontier technology to positively impact society. We invest globally in the early stages, actively supporting founders via our collective of global entrepreneurs.
Show more
Investment focus
  • Software, Information Technology, Biotechnology
  • Seed, Pre-Seed, Series A
  • Germany, Australia, United States
Portfolio highlights
  • Heidi Health — Heidi Health is modernizing primary care with AI-powered technologies to improve care's quality and accessibility. its creators and engineers is to completely eradicate missed and sluggish diagnoses worldwide. They are committed to bridging the gap between the level of care that patients desire and the level of care that doctors can delivergiven their budget constraints. To create a platform where patients can quickly and easily get the treatment they require and to give every clinician the resources they need to deliver care that is secure, efficient,
  • Zafrens — Zafrens specializes in developing tools and generating insights at the interface of biology, chemistry, and engineering. The company was founded in 2021 and is headquartered in San Diego, California, United States.
  • Cosmic Aerospace — Cosmic Aerospace is a pioneering aerospace technology company dedicated to advancing the boundaries of propulsion systems and enabling innovative solutions for space exploration. The company collaborates with leading space agencies, research institutions, and commercial partners to design, test, and implement these groundbreaking technologies.
IBB Ventures VC Fund · Berlin, Berlin, Germany · 9 investments in the past 12 months
IBB Ventures is a venture capital and mezzanine arm of Investitionsbank Berlin specializing in seed/startup, early venture, and mid venture investments. The firm invests in technology-oriented companies and companies from the creative industries. It typically invests in information and communication sector with a focus on hardware andsoftware, network technology, new media, and internet and mobile technologies; life science sector with a focus on biotechnology and media technology; and industrial technologies sector with a focus on software, PPS, supply chain management, micro and nanotechnology, environmental and power technology, automation, manufacturing technology, transport technology and logistics, and new materials. The firm also invests in movies, broadcast, television, publisher, music, entertainment, advertising, fashion, design, architecture, multimedia, games, software, and art and culture. It invests in companies based in Berlin. It typically invests between €0.25 million ($0.32 million) and €3 million ($3.83 million) per transaction. The firm prefers to take a board seat in its portfolio companies. IBB Ventures was founded in 1997 and is based in Berlin, Germany.
Show more
Investment focus
  • Software, Health Care, Internet
  • Seed, Funding Round, Series A
  • Germany, United States, United Kingdom
Portfolio highlights
  • Quantistry — Move beyond traditional chemical simulation software and boost your R&D success. From Quantum to AI. Get started!
  • Meloon — Meloon captures and converts carbon dioxide from the atmosphere.
  • Elucid Social — Elucid Social integrates businesses with the social good movement through a data-driven strategy that yields measurable results. Elucid Social develops and deploys technologies to assess, report, and minimize human rights risks linked with the sourcing of products and services.
HV Capital VC Fund · Munich, Bayern, Germany · 21 investments in the past 12 months
We support exceptional founders in building market leading digital companies.
Show more
Investment focus
  • E-Commerce, Internet, Software
  • Series A, Seed, Series B
  • Germany, United Kingdom, United States
Portfolio highlights
  • Midas — U.S. Treasuries, On-chain.
  • Creator.Bid — Creator.Bid allows content creators to create AI-driven digital assets to monetize their content.
  • Bitlight Labs — Bitlight Labs builds infrastructure using the RGB protocol and the Bitcoin Lightning Network.
Atlantic Labs VC Fund · Berlin, Berlin, Germany · 14 investments in the past 12 months
Atlantic Labs supports and invests in mission-driven founders working on transformative technology ventures.&nbsp;<br><br>We partner with founders early, providing the capital, tools and network necessary to growing their companies and accompanying them on their entrepreneurial journey. We are currently active in areas including Digital Health, Future of Work, Machine Learning, Decentralized Networks, Mobility and Industrial Applications.
Show more
Investment focus
  • Software, Health Care, Information Technology
  • Seed, Pre-Seed, Series A
  • Germany, Switzerland, United States
Portfolio highlights
  • Heyflow — Create better customer interactions with conversational flows. More personal. More conversions. Build your flow today! No coding required.
  • Embea — Embea takes Embedded Insurance to Life & Health. Our easy-to-understand plans protect families against the most severe life risks of critical illnesses, accidents, and death. Companies of every size embed our simple and transparent insurance products into their apps and services. Embea removes complexity, paperwork, and pushy sales from theworld of life insurance. Our vision is a world where fair and affordable insurance is accessible to everyone.
  • 150 Minuten — Das Startup 150Minuten aus Berlin möchte Menschen aller Alters- und Fitnessklassen für mehr Sport und Bewegung begeistern. Wir bieten ein modernes, interaktives Online-Kursangebot, an dem jede*r (direkt und live) von Zuhause aus teilnehmen kann.
Brandenburg Kapital VC Fund · Potsdam, Brandenburg, Germany · 4 investments in the past 12 months
With a track record of over 20 years in venture capital and experience from more than 200 investments in numerous companies BFB Brandenburg Kapital GmbH (BFB) is the most active equity investor in Brandenburg. BFB invests in fast-growing technology-orientated companies throughout the whole life-cycle. Target sectors are ICT/Digital Economy,Life Science, MedTech, Proptech, Industrial Applications. BFB invests in companies based in or with facilities in Brandenburg. The current VC fund is financed by the European Regional Development Fund (ERDF) an Investitionsbank des Landes Brandenburg (ILB).
Show more
Investment focus
  • Information Technology, Software, Health Care
  • Seed, Series A, Funding Round
  • Germany, United Kingdom
Portfolio highlights
  • Seqstant — Seqstant offers the LiveGene platform for real-time pathogen analysis, allowing for sensitive, specific, and user-friendly real-time genetic diagnostics.
  • IQONIC.AI — Creating AI Solutions for Skin, Hair & Inner Balance
  • Doctorflix — Doctorflix is a medical education platform that allows doctors around the globe to learn about methods of treatment while accelerating their system-required professional development. We are on a mission to build an engine that simplifies and democratizes the consumption and exchange of medical knowledge by interlinking doctors, hospitals, andpharmaceutical companies.
EQT Life Sciences VC Fund · Amsterdam, Noord-Holland, The Netherlands · 13 investments in the past 12 months
EQT life science develops innovative medicines, devices, and tools to address the single important thing that matters to the preservation of health. The organization believes that such opportunities add value to all stakeholders.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Series C
  • United States, The Netherlands, Switzerland
Portfolio highlights
  • Phagenesis — Phagenesis is developing a device for the treatment for dysphagia, the inability to swallow safely, that often accompanies stroke or other neuro-deficit diseases. The approach is to harness the brain's own capacity for relearning functions that have been lost through brain damage (via "neuroplasticity" or "corticalremapping"). Focusing initially on the care of stroke patients as they recover in hospital (acute care), Prof Shaheen Hamdy of the University of Manchester, UK, painstakingly devised a method of delivering electrical signals from the pharynx (throat) along nerve cells directly to the relevant parts of the brain. The results of his work have been published in top peer-reviewed scientific and medical journals, including The Lancet, the Nature group of publications, and Gastroenterology.
  • Onera Health — Introduction to Onera sleep diagnostics and monitoring solutions
  • Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and
seed + speed Ventures VC Fund · Berlin, Berlin, Germany · 4 investments in the past 12 months
Empowering visionary founders with pre-seed and seed funding for B2B software innovation. Partner with us to turn your aspirations into thriving businesses. Our expert support ensures your journey to success.
Show more
Investment focus
  • Software, SaaS, Health Care
  • Seed, Pre-Seed, Series A
  • Germany, Austria, Switzerland
Portfolio highlights
  • happyhotel — The happyhotel revenue and yield management system has a simple dashboard that supports the hotelier in the data analysis of the most important hotel KPI’s. happyhotel is a cloud-based hotel software specially designed for small and medium-sized hotels. Hoteliers can achieve more revenue without a great deal of prior knowledge. The hotelier getpast, current and future values of RevPar, Occupancy, ADR and Revenue. Through the booking pace graph and the on the books evaluation the hotelier can react to the current market conditions. Furthermore the hotelier can review every day the important reports and get an alert if the values do not correspond with the budget. happyhotel use a special formula and an algorithm who gives the hotelier the best price recommendation for his hotel or each of your hotel segments and room types. With an interface to the hotel pms happyhotel get all data to analyze the hotel. happyhotel facilitates the hotelier's life through automatic processes so that he can concentrate on other things.
  • Helio — Carbon Aware Cloud Computing.
  • Tokenize.it — Tokenize.it are developing non-custodial token-based fundraising methods.
Rheingau Founders VC Fund · Berlin, Berlin, Germany · 2 investments in the past 12 months
Rheingau Founders is a Berlin&Munich based Venture Capital firm active since 2011. Focusing on pre-seed to Series A investments in Europe, predominantly B2B in the fields of Marketplaces, Software as a Service, InsurTech, and eHealth. Rheingau targets start-ups that have the potential to sustainably disrupt existing processes and value chains.Besides the financial investment, we offer strategic support through the mentorship of our partners.
Show more
Investment focus
  • Software, E-Commerce, Internet
  • Seed, Series A, Pre-Seed
  • Germany, United States, Poland
Portfolio highlights
  • NetBird — Wiretrustee is an open-source VPN platform built on top of WireGuard® making it easy to create secure private networks for your organization or home. It requires zero configuration effort leaving behind the hassle of opening ports, complex firewall rules, VPN gateways, and so forth.
  • MoleQlar — MoleQlar is a data and research-driven longevity company. It provides valuable information and offers consumers lab-tested nutritional supplements. The company focuses on functional medicine with optimized nutrition. Their product range includes Uthever NMN, Resveratrol, Betaine, Carnosine, and more. These products are aimed at lowering biologicalage and promoting health and longevity. MoleQlar also offers health tracking services. The company is certified in Germany and delivers its products EU-wide, including Switzerland.
  • Akhetonics — Creating the first all-optical RISC Processor
WestTech Ventures VC Fund · Berlin, Berlin, Germany
WestTech Ventures is a Berlin-based VC firm focused on pre-seed & seed investments primarily in Germany in the fields of B2B SaaS in different verticals, and Enterprise Software as well as Mobility and New Work.
Show more
Investment focus
  • Software, Internet, Information Technology
  • Seed, Series A, Funding Round
  • Germany, United States, France
Portfolio highlights
  • Notch — Boost your deal win rates and customer onboarding with Notch. Create tailored buyer experiences, structured action plans, and gain valuable insights. Try our demo today.
  • Careloop — Berlin-based HR-tech and EduTech startup with a focus on the German healthcare industry.
  • THE CLIMATE CHOICE — The software platform for decarbonizing companies and their supply chains.
BayBG Venture Capital VC Fund · München, Bayern, Germany · 4 investments in the past 12 months
Innovative post-revenue startups with first customers trust us as highly reliable investors. We have been an active player in the venture capital market for over 25 years. Due to our evergreen approach, we offer institutional venture capital without the limitations of the usual fund structure. Predominantly we invest straight equity. Additionally,we can offer venture debt to mature startups close to break-even in order to avoid further dilution for founders. Being a private investment company we act as both lead investor or co-investor. We can also fulfill the private lead investor role for public investors like Bayern Kapital. Together we are increasing YOUR company's value.
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Funding Round, Series A, Series B
  • Germany, Italy, United States
Portfolio highlights
  • memtime — memtime shows you everything you worked on during the day. Each program is recorded so that you can quickly remember. Add-on available for any software. | memtime
  • SUSHI Bikes — SUSHI Bikes has developed the perfect e-bike for modern urban people.
  • Kloster Kitchen — Kloster Kitchen is a monastery kitchen as the root of unique taste.
DvH Ventures VC Fund · Köln, Nordrhein-Westfalen, Germany · 3 investments in the past 12 months
Investing early in Europe's most passionate founders.
Show more
Investment focus
  • Health Care, Financial Services, Software
  • Seed, Series A, Funding Round
  • Germany, Austria, United Kingdom
Portfolio highlights
  • OneTwenty — OneTwenty is an early-stage health tech start-up that develops multiple Machine Learning based solutions for people with diabetes as well as Medtech companies for sensor optimization, biomarker prediction, glucoregulatory models, and iAGC (interoperable automated glycemic controller). Our solution demonstrates unprecedented precision in bloodglucose prediction 120 minutes in advance. OneTwenty revolutionizes the life of people with Type 1 diabetes.
  • Dr. Vivien Karl — Dr. Vivien Karl relies on a cream for moisturizing care against vulva dryness.
  • Broken String Biosciences — Our platform accelerates the characterisation of novel gene editing technologies to unlock the next wave of cell & gene therapies.
Vorwerk Ventures VC Fund · Berlin, Berlin, Germany · 2 investments in the past 12 months
Vorwerk Ventures is an independent €150m Venture Capital Fund grown out of the Vorwerk Group in late 2019 and defines itself through a strong commitment towards consumer-facing digital businesses. Our unique direct selling experience in addition to an outstanding track record in Venture Capital provides added value for forward-thinkingentrepreneurs. Headquartered in Berlin Germany, we currently have more than €250m in assets under management and are constantly on the look-out for promising opportunities starting with Seed/Series A investments of €1m to €10m and ensuring continuous support reserving up to €15m for upcoming financing rounds. An outstanding founding team, an existing market presence and a well-defined exit strategy framed by a consumer-centric business model are key requirements to us when it comes to making an investment decision.
Show more
Investment focus
  • E-Commerce, Health Care, Food and Beverage
  • Seed, Series A, Series B
  • Germany, United Kingdom, Switzerland
Portfolio highlights
  • Sunhero — Sunhero delivers custom-built solar panel solutions. Sunhero offers consumers a hassle-free method of installing customised photovoltaic solar systems on their homes, be that either purchasing outright or renting for a 20 year period.
  • CarbonPool — Innovative carbon credit insurance which pays claims in carbon credits, not cash. See how we can help you.
  • Sorella Care — Sorella is the first network of multidisciplinary health places for women. Sorella ensures that every woman, regardless of age, has access to a comprehensive care pathway offered by women's health specialists.
Sparkasse Jena VC Fund · Jena, Thuringen, Germany
Sparkasse Jena is a German savings bank offers a collection of financial products and services to private, retail, and corporate customers.
Show more
Investment focus
  • Medical, Shopping, E-Commerce
  • Seed, Series A, Series C
  • Germany, United States
Portfolio highlights
  • ShopCo Technologies — Shop uses Artificial Intelligence to empower online shopping experience for customers. It is a universal shopping cart browser extension that keeps all the items of its users across the web in one spot. Stores can be registered online and without any hassle. It helps its users browse through a wide range of online stores and checkout from one spot.The company gives ability to connect to all its users existing retailer accounts. It also secures data with encryption methods and two-step verifications. Shop is a U.S.-based company that was founded in 2014 by Jay Habib.
  • NovaPump — The NovaPump GmbH is a cardiology company based in Jena/Germany devoloping cutting-edge therapeutical solutions in the field of non-invasive and percutaneous circulation support. The so called PERKAT (PERKutane KATheterpumpe) technique will be offered as pLVAD & pRVAD heart pumps for acute left or right heart patients within the nextyears. PERKAT works together with the current IABP technique (intra aortic balloon pump with about 200,000 cases p.a. internationally) and is the only-one catheter-based & self-expanding, pulsatile & ECG-triggered, cost-effective heart pump technique with a high pump performance. PERKAT is not available on the market so far. Articles in leading scientific journals and presentations at the top four international cardiology conferences in the last years show the medical need, the development status and the technological and medical advantages of PERKAT.
  • Dynamic42 — Dy­nam­ic42 provides, customizes innovative 3D mi­cro­phys­i­o­log­i­cal in vit­ro test systems recre­at­ing human organ key functions. It develops and markets novel, three-dimensional, human organ models (scalloped organ-on-chip technology) for pre­clin­i­cal research and developmental, as well as for testing novel pharmaceutical products,chemicals, and food additives. It is specialized in the area of organ-on-chip technology in the integration of the immune system, which plays a significant role in the occurrence of adverse effects of drugs and has been neglected in the industry and in two-dimensional test systems.
Playground Global VC Fund · Palo Alto, California, United States · 7 investments in the past 12 months
Playground is an early-stage investment firm that helps old and new investors and entrepreneurs working at the intersection of bits, atoms, and AI. It focuses on investment, innovation, connected hardware, artificial intelligence, and robotics.
Show more
Investment focus
  • Software, Robotics, Artificial Intelligence
  • Series A, Seed, Series B
  • United States, Canada, France
Portfolio highlights
  • Boxbot — Dynamic storage and retrieval platform that adapts to varying cubic dimensions and eliminates manual pick stations.
  • Insamo — Insamo is a global biotechnology company pioneering the discovery of membrane-permeable and orally available cyclic-peptides with antibody-like binding affinity.
  • Element Zero — Element Zero - The Green Metal Company. Element Zero has developed a novel approach to cost-effectively and efficiently convert metal ores such as iron ore, nickel ore and other future facing metals, to pure metal form with zero carbon emissions.
Global Asset Fund VC Fund · Landshut, Bayern, Germany
Global Asset Fund is a private equity firm based in Germany that finances early and later stage venture investments. The fund enables the development of products and technologies that address a growing market of tomorrow.
Show more
Investment focus
  • Medical, Therapeutics, Biotechnology
  • Series A, Series B, Funding Round
  • Germany
Portfolio highlights
  • Siltectra — SILTECTRA is a high-tech company specializing in kerfless wafering and thinning, an innovative new technology for manufacturing wafers. Kerfless wafering by SILTECTRA is a platform technology which can be used in a wide variety of industries and for many different materials.
  • Isarna Therapeutics — Isarna Therapeutics has an unmatched commitment to developing selective TGF-β inhibitors to effectively treat ophthalmic diseases. They are advancing a unique pipeline of novel oligonucleotides and combination modalities to transcend clinical response and improve patient outcomes.
Boehringer Ingelheim Venture Fund VC Fund · Ingelheim Am Rhein, Rheinland-Pfalz, Germany · 3 investments in the past 12 months
The Boehringer Ingelheim Venture Fund is the strategic venture fund of the Boehringer Ingelheim Corporation.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Seed
  • United States, Germany, Belgium
Portfolio highlights
  • Actym Therapeutics, Inc. — Actym Therapeutics is developing key biotech to help target intractable immune pathways in the tumor microenvironment.
  • smartbax — We develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms.
  • Glox Therapeutics — Developing novel precision antibiotics based on protein bacteriocins, to target Gram-negative Antimicrobial Resistant (AMR) pathogens.
Forbion Capital Partners VC Fund · Naarden, Noord-Holland, The Netherlands · 10 investments in the past 12 months
Impacting the future of medicine.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series B, Series A, Series C
  • United States, United Kingdom, The Netherlands
Portfolio highlights
  • Calluna Pharma — Join Calluna Pharma on our mission to revolutionize the treatment of inflammatory and fibrotic diseases. With a robust pipeline, seasoned leadership, and strategic alliances, help us reshape the treatment landscape for the better.
  • Orbis Medicines — Orbis Medicines is a novel macrocyclic chemistry and computational platform for high-throughput drug discovery.
  • Engrail Therapeutics — Engrail delivers transformational therapies that improve the lives of patients with devastating neurologic, neuropsychiatric, and neurodevelopmental disorders.
Vesalius Biocapital Partners VC Fund · Strassen, Luxembourg, Luxembourg · 2 investments in the past 12 months
Vesalius Biocapital Partners invests in companies active in human health through venture capital funds raised since 2007. They have contributed to developing 20 companies since inception.With more than € 150 million under management in two funds. Vesalius Biocapital Partners plays the role of lead investor in the large majority of its financingrounds.Their companies are based in Europe allowing easy interaction with management.They invest in all stages of development and do not shy away from relatively early-stage projects with a sound proprietary technology and corresponding IP, unique team skills and a clear competitive edge based on solid data.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series B, Series A, Series C
  • Belgium, Germany, The Netherlands
Portfolio highlights
  • CatalYm — Catalym develops antibodies against a placental factor which is overexpressed by various tumour types.
  • Scenic Biotech — We are pioneers in the discovery of genetic modifiers to enable the development of transformative therapeutics.
  • Memo Therapeutics — Memo Therapeutics AG (MEMO) is an innovator in the field of antibody discovery and immune repertoire analysis.Its MemoMAB™ platform creates a recombinant in vitro copy of an individual’s B cell / antibody repertoire, which is then banked as a library. The resulting unique, large and relevant antibody libraries represent the individual’simmune repertoire and are expected to contain an unprecedented number of relevant and rare antibodies. This leads to entirely new possibilities in immune repertoire analysis and antibody discovery.MemoMAB™ is deployed in proprietary antibody lead discovery programs and is made available in collaborations.
Born2Grow VC Fund · Heilbronn, Baden-Wurttemberg, Germany
Born2Grow is a german venture fund focusing on early stage investments. They invest up to 500k€ in innovative business models. They are based in Heilbronn in Baden-Wuerttemberg. Born2Grow focus on investments lies within the MedTech, BioTech, FinTech area as well as some other online industries
Show more
Investment focus
  • Software, Health Care, Medical
  • Seed, Series A, Series B
  • Germany, Finland, United States
Portfolio highlights
  • Semorai — Semorai - Intelligent error management for manufacturers We are reinventing the future of quality and error control in the industrial industry with our unique AI-as-a-Service solution.
  • Doinstruct — Doinstruct offers mobile training solution for frontline workers.
  • traplinked — Digitale Fallensysteme - Endlich wissen, was los ist! Mit den traplinked Sensormodulen JERRY und TOM erhalten Sie in Echtzeit ein digitales Abbild Ihrer Kontrollpunkte.
MBG Baden Wuerttemberg VC Fund · Stuttgart, Baden-Wurttemberg, Germany
MBG Baden Wuerttemberg is an investment company that helps small and medium sized companies strengthen their capital base.
Show more
Investment focus
  • Software, Health Care, Information Technology
  • Seed, Series A, Series B
  • Germany
Portfolio highlights
  • Idana — Mit Idana befragen Sie Patient:innen vorab digital. Entlasten Sie Ihr Team und begeistern Sie Ihre Patient:innen.
  • stimOS — Smart implants made in Germany and ISO 13485:2016 certified: Addressing the patient's need for better osseointegration and less inflammatory reactions. Surface modification technology for better clinical results. Evidence based: MBT is a golden standard technology for spinal fusion, dental applications and CMF implant.
  • AZOWO — 2in1 vehicle data & software solution by Azowo. We enable our customers to build and manage all critical shared, connected, electric and autonomous processes.
Enjoyventure Management VC Fund · Düsseldorf, Nordrhein-Westfalen, Germany · 2 investments in the past 12 months
The EnjoyVenture Management is a private equity company that focuses its investments on the seed and early-stage companies.
Show more
Investment focus
  • Software, Information Technology, E-Commerce
  • Seed, Series A, Funding Round
  • Germany, Portugal, United States
Portfolio highlights
  • coapp — coapp brings people and resources together under your brand and handles social and financial transactions between them. Easy!
  • MARCLEY — MARCLEY provides a system that enables multi-family building apartment owners to utilize solar energy on their roofs without any financial commitment or additional effort. The generated green power is sold at a cheaper cost than the local basic utility.
  • Careloop — Berlin-based HR-tech and EduTech startup with a focus on the German healthcare industry.
SV Investment Corp VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 11 investments in the past 12 months
SV Investment Corp is a venture capital firm that provides companies with finance, strategic advice and information at critical stages of their development.
Show more
Investment focus
  • Information Technology, Medical, Software
  • Series A, Series B, Seed
  • South Korea, United States, Germany
Portfolio highlights
  • Aniai — Need robots that can cook some REAL BURGERS, follow your recipe to the letter, and help you to make it even better?
  • MyRealTrip — MyRealTrip is leading tours&activities marketplace in South Korea. MyRealTrip is the best free travel platform in Korea where you can book flights, accommodations, tours & tickets, and special offers. Starting with guided tour service in 2012, it has been growing rapidly since it successfully launched air service in 2018. MyRealTrip isconstantly striving to provide travelers with a personalized experience and provide them with a more valuable experience.
  • Rebellions.ai — AI chip architects are often inattentive to advanced deep learning features and requirements because they believe software stacks between their silicon and algorithms can provide effective abstract layers. We disagree. We do not think such naively designed chips can efficiently utilize expensive custom silicon resources. The more native hardwaresupports are enabled, the higher performance is achieved.Rebellions Inc is building genuine AI accelerators by bi-directionally bridging the gap between underlying silicon architectures and deep learning algorithms. We push algorithm boundaries to better exploit silicon budgets, while re-architecting AI processors to incorporate sophisticated deep learning features through silicon-dedicated DL kernels.Our goal is to deliver a domain-specific AI processor along with its optimized software. This approach, together with our unique decentralized programming model, will enable customers to arm with the most powerful yet energy-efficient AI hardware as well as seamless integration.
WEGVISOR VC Fund
We effectively support start-ups through early-stage capital, network, know-how, follow-up financing and personality development.
Show more
Investment focus
  • Manufacturing, Medical, Internet
  • Seed, Pre-Seed, Convertible Note
  • Germany
Portfolio highlights
  • BDK Group — Autoglas der Zukunft
  • Infrasolid — Innovative infrared sources for gas detection & spectroscopy. Infrasolid's infrared radiation sources are based on a patented nanotechnology in combination with the self-supporting monolithic structure.
  • Suburban Seafood — Premium producer of shrimp larvae and prawns.
Andera Partners VC Fund · Paris, Ile-de-France, France · 10 investments in the past 12 months
Andera Partners, formerly known as Edmond de Rothschild Investment Partners (EdRIP) As heir to the traditions and values that have ensured the success of the Rothschild family for 250 years, the Edmond de Rothschild Group has established itself over time as a leading player in European finance. Its activities are grouped around two major areas:Private Banking and Asset Management. The Group offers wealthy families, entrepreneurs, and large institutions a full range of solutions combining a culture of tailored solutions, stability, performance, and innovation. The Edmond de Rothschild Group’s offering is characterised by strong convictions, with the desire to guarantee to each of its customers: A unique, close relationship, underpinned by the know-how and the variety of expertise of a large international group; Autonomous, experienced teams, who anticipate economic trends and innovate to establish long-term performance; The recognised stability, strength, and independence of a family-owned financial group. Founded by Baron Edmond de Rothschild in 1953, the Group has been chaired by his son, Baron Benjamin de Rothschild, since 1997.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series B, Private Equity, Funding Round
  • France, United States, Germany
Portfolio highlights
  • MMI — The future of Microsurgery: microinstruments that expand the possibilities of surgical interventions. Wristed robotic microinstruments for unprecedented results in microsurgery.
  • ENYO Pharma — ENYO Pharma is a biopharmaceutical company incorporated in Jan, 2014, by four scientists of the Infectiology Research Center in Lyon, France, and three seeding partners (2 privates and 1 public).The company is based in the Infectiology Center of Lyonbiopôle in Lyon, France and maintains tight collaborations with the seminal Inserm team and theBSL4 laboratory Inserm-Jean Mérieux.ENYO Pharma has licensed several Inserm patents issued from the discoveries of the founding scientists and developed a unique platform for the identification of intracellular therapeutic targets and molecules.The company is developing treatments against the most important viruses and is thriving to become a global leader in anti-virals. Research and Development is currently focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company plans to conduct its molecules to Phase II clinical trials.
  • Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and
HBM Healthcare Investments AG VC Fund · Zug, Zug, Switzerland · 3 investments in the past 12 months
As a venture capital company, HBM BioVentures is invested globally in some 40 mature emerging companies in the biotechnology/human medicine, diagnostics and medical technology sectors. The primary products of HBM BioVentures' portfolio companies are either at an advanced stage of development or already available on the market. The companyfocuses on unquoted emerging companies, with two-thirds are invested in private companies that offer high value creation potential. This has enabled HBM BioVentures to carve out a unique and distinctive market position. HBM BioVentures has a broad shareholder base and is listed on the SIX Swiss Exchange (ticker: HBMN).
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series B, Series C, Series A
  • United States, Switzerland, China
Portfolio highlights
  • Upstream Bio — Upstream Bio focuses on developing an antibody therapy for the treatment of severe asthma. Upstream Bio was founded in 2004 and was headquartered in the United States.
  • Vicore Pharma — Vicore Pharma is a pharmaceutical company dedicated to developing innovative medicines for severe lung disorders. It develops drugs that act through the AT2 receptor. The company’s drug candidate C21 aims to improve the treatment of idiopathic pulmonary fibrosis, a rare disease for which C21 has been granted orphan drug designation both in the EUand the US. In addition, C21 is explored pre-clinically in a number of rare diseases where the AT2 receptor plays an important role. The company is based in Astra Zeneca’s Bioventurehub in Mölndal.
  • Odyssey Therapeutics — Odyssey Therapeutics is developing innovative medicines to make extraordinary leaps in outcomes for patients with cancer inflammatory diseases
Aescuvest VC Fund · Frankfurt, Hessen, Germany
Aescuvest’s mission is to facilitate and enable impactful investments into medical breakthrough innovation to disrupt and improve healthcare delivery models, products, and services. Aescuvest enables its investors to build their very individual portfolio of healthcare start-ups - according to their personal investment focus. A cooperation with EITHealth, and a growing network of partnerships across Europe, allow Aescuvest to source and evaluate the most promising healthcare investment opportunities, structure their financing rounds, and enable healthcare technology-driven investors, such as Business Angels, HNWIs, Family Offices, and Corporate Investors, to participate in healthcare investment opportunities by direct investments via SPV structures. The Investment Committee, composed of Aescuvest’s very own investment team and members of tthe Advisory Board of Aescuvest, both deeply rooted in the healthcare industry and with proven track records, have developed a strong and over the last years well tested, pre-screening and due diligence process, to identify and select healthcare start-ups. Aescuvest’’s Management (circle of General Partners) put their ‘skin’ into each investment by committing capital to each company prior introduction to the wider Aescuvest investor base. The combination of innovative ways for equity capital provision, with healthcare industry and investment expertise, provides the Aescuvest portfolio companies a unique platform to develop their business solution, accelerate their path towards commercialization, and lower market access barriers.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Equity Crowdfunding, Seed, Pre-Seed
  • Germany, The Netherlands
Portfolio highlights
  • XO Life — XO Life is to build the largest real-world evidence platform for patient insights for all medications and therapies. Together with one of Europe's leading research institutes for patient-centered research, the PROMIS Institute Germany of the Charité, and various pharmaceutical manufacturers, patient experiences are to be recorded in astandardized and systematic manner across a wide range of diseases. Patients are to be enabled to record their therapy course and outcome independently as well as scientifically validated so that these patient insights from real treatment practice can be used in the life science industry and by medical professions.
  • Lillian Care — Lillian is building a nationwide network of health facilities in Germany.
  • medikura.com — MEDIKURA develops digital infrastructure for drug safety. The goal is to make the drug safety as safe as possible.
Global Founders Capital VC Fund · Berlin, Berlin, Germany · 23 investments in the past 12 months
Over the past two decades, GFC have backed over five hundred entrepreneurs worldwide, e.g. Facebook, LinkedIn, Slack, and Away Travel.
Show more
Investment focus
  • Financial Services, Software, FinTech
  • Seed, Series A, Pre-Seed
  • United States, Germany, United Kingdom
Portfolio highlights
  • Zocks — The Meeting Assistant made for Financial Advisors
  • Simplify — Simplify is a common application for jobs & internships. Autofill job applications anywhere on the web, get notified when new jobs open, & seamlessly track your applications.
  • Smartpay — Smartpay is the first free of charge BNPL payment option for Japanese consumers who have credit cards. There are no sign-up fees, interest fees, settlement fees, or late charges. The payment experience is also Japan’s first cross-merchant, cross-platform, and single-click checkout BNPL service, allowing consumers to checkout in as little as 10seconds. The BNPL payment solution is simple to understand, structured on 3 equal installments over 8 weeks. This means that unlike the existing BNPL services in Japan, customers do not need to go to the convenience store to make payments or pay any bank transfer fees.
Initiative for Industrial Innovators VC Fund · München, Bayern, Germany
Initiative for Industrial Innovators aim at funding up to 2,000 disruptive deep tech solutions until 2024 through our fast funding instruments. The Initiative for Industrial Innovators enables local ecosystems, each consisting of a local multi-generational Family Office, a local innovation center, and a local technical university, to join forces.
Show more
Investment focus
  • Software, Medical, Health Care
  • Seed, Pre-Seed, Series A
  • Germany
Portfolio highlights
  • OCELL — Building the Operating System of Sustainable Forestry
  • Filics — A scalable transport solution for standardized load carriers with a minimum energy footprint
  • FERNRIDE — Fernride enables automated, sustainable logistics by combining the skills of remote drivers with autonomous technologies.
Antler VC Fund · Singapore, Central Region, Singapore · 114 investments in the past 12 months
Build your next company with Antler, a global day zero investor enabling exceptional founders to start great companies, from the very beginning. Apply now!
Show more
Investment focus
  • Software, Information Technology, SaaS
  • Pre-Seed, Seed, Series A
  • Singapore, United Kingdom, Australia
Portfolio highlights
  • Immibot — Get assistance from our AI-powered chatbot on your immigration journey. Our model is trained on official regulations to answer any questions you may have on how to move abroad.
  • Quench.ai — Quench is a tech infrastructure for video creators to deliver exclusive content, engage and reward their true fans.
  • Source — Source is an AI-powered recruitment platform that makes tech talent sourcing fast, precise, and cost-effective.
SHS Capital VC Fund · Tübingen, Baden-Wurttemberg, Germany
Mission With our investments, SHS Capital supports fast-growing companies in their mission to become European healthcare champions. Located in the &hellip;
Show more
Investment focus
  • Health Care, Medical Device, Medical
  • Funding Round, Series C, Series A
  • Germany, Switzerland, France
Portfolio highlights
  • MESI Medical — The MESI mTABLET provides predictive medical assessment with a wide selection of hardware modules, software extensions and different integration options.
  • Dr.Dropin — Dr.Dropin an accessible and modern private health service that offers the vast majority of medical services at a fixed price.
  • Simulands — Human grade cardiovascular simulators
Project A Ventures VC Fund · Berlin, Berlin, Germany · 10 investments in the past 12 months
Project A is an early-stage venture capital firm, combining financial and operational support for technology companies. In addition to $600 M in assets under management, Project A provides its portfolio companies with a wide range of operational support services. This includes more than 100 experts from key areas such as software engineering,business intelligence, marketing, and recruiting. The portfolio includes companies such as Trade Republic, sennder, KRY, Catawiki, WorldRemit, Spryker, and Voi.
Show more
Investment focus
  • Software, E-Commerce, Information Technology
  • Seed, Series A, Series B
  • Germany, United Kingdom, United States
Portfolio highlights
  • Heyflow — Create better customer interactions with conversational flows. More personal. More conversions. Build your flow today! No coding required.
  • Mindfuel — Our Data Product Management software solution and value services help increase transparency across the entire value chain, slash costs and boost your data ROI.
  • Labrys Technologies — Visualise & Coordinate Your People. Securely. Anywhere. In Real-Time.
European Investment Bank VC Fund · Luxembourg, Luxembourg, Luxembourg · 27 investments in the past 12 months
European Investment Bank (EIB) provides lending, borrowing, and treasury services primarily in the European Union.The company offers project loans for the public and private sectors; loans to banks and other intermediaries; structured finance products; guarantees and securitization instruments for senior and subordinated debts; project bonds;equity and fund investment products such as infrastructure equity and debt funds, and environmental funds; and venture capital funds and security packages for funds.The company also offers microfinance; risk sharing finance for research, development, and innovation projects; finance and technical expertise for sustainable energy projects; infrastructure project advisory services; support for urban development projects; guarantees for transport infrastructure; and funding for public-private partnerships and small- and medium-sized enterprises.EIB serves the transportation, global loans, energy, industry, health, education, water, sewerage, infrastructure, services, telecommunications, agriculture, and fisheries sectors.European Investment Bank was founded in 1958 and is based in Luxembourg.
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Debt Financing, Post-IPO Debt, Funding Round
  • France, Germany, The Netherlands
Portfolio highlights
  • Eldrive — The largest charging point operator in Eastern Europe | Our network is expanding rapidly yet our focus is fixed on renewables, for a greener future. We provide AC & DC charging across Bulgaria, Romania and Lithuania.
  • ABN AMRO Bank — Als bank leggen wij de focus op inclusiviteit, duurzaamheid, sociaal ondernemen, innovatie, dagelijkse bankzaken en meer.
  • Enel Green Power — Enel Green Power is the company that deals with renewable energy from every perspective: from direct sales through PPA, to commitment at the forefront with its plants worldwide.
German Federal Ministry of Education and Research (BMBF) VC Fund · Bonn, Nordrhein-Westfalen, Germany
German Federal Ministry of Education and Research (BMBF)
Show more
Investment focus
  • Biotechnology, Medical, Health Care
  • Grant, Seed, Series B
  • Germany, United States, Denmark
Portfolio highlights
  • InflaRx — InflaRx develops new therapeutics in the field of acute and chronic inflammation and consists of a team of internationally recognized researchers and clinicians who have dedicated their careers to translate discoveries and expertise into new therapeutic concepts for clinical application.In April 2018, InflaRx conducted a USD 117 million totalgross proceeds follow-on transaction on the US Nasdaq global select market comprised of a primary component of USD 63 million investment into InflaRx as well as a secondary component of USD 54 million to existing first-day shareholders of InflaRx. InflaRx was founded in December 2017 and is headquartered in Jena, Germany.
  • Evotec — Evotec is a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with pharmaceutical and biotechnology companies, academics, patient advocacy groups, and venture capitalists. Drug discovery solutions are provided in form of fee-for-service work, integrated drug discovery alliances,development partnerships, licensing of innovative drug candidates, and consulting arrangements. The company operates worldwide and has leading scientific experts, state-of-the-art technologies as well as key therapeutic expertise in the areas of neuroscience, diabetes, and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases, and fibrosis. By leveraging this expertise, Evotec intends to develop best-in-class and first-in-class differentiated therapeutics on its systematic, unbiased, and comprehensive infrastructure.Evotec has long-term discovery alliances with partners including Bayer, Boehringer Ingelheim, Celgene, CHDI, Novartis, Novo Nordisk, Pfizer, Sanofi, Takeda, UCB, and others. In addition, the company has existing development partnerships and product candidates both in clinical and pre-clinical development. These include partnerships with Sanofi in the field of diabetes and cancer immunotherapy, with Pfizer in the field of tissue fibrosis, with Bayer in the field of kidney diseases, and with Celgene in the field of neurodegenerative diseases.
  • NVision Imaging Technologies — NVision Imaging Technologies is leveraging advances in quantum physics to enable the first routine, convenient and affordable use of Magnetic Resonance Imaging (MRI) for assessing early patient response to cancer treatment at the metabolic level.
Green Park & Golf Ventures VC Fund · Dallas, Texas, United States
Green Park & Golf, built on over 50 years of operational and financial experience, seeks investment opportunities that offer above-market returns for its investors. Led by Clay Heighten, M.D., and Carl Soderstrom, the Firm delivers strategic solutions, financial backing and a reliable network to its portfolio companies. The Dallas-based Firm iscurrently looking for investment opportunities in medical-related start-ups.Dr. Heighten founded MedicalEdge Healthcare Group in 1993, and Mr. Soderstrom started PhyServe Physician Services in 1998 to administer the financial and operational needs of MedicalEdge. Together, the companies managed over 550 providers in five major markets. In 2011, the companies were sold to Texas Health Resources, a $3.8 billion health care system. That’s when Green Park & Golf was born.After earning his MBA at Southern Methodist University, Mr. Garcia joined them full-time in May 2011 to actively pursue new investment opportunities and monitor other investments in their portfolio. He has prior professional experience at FedEx, Bold Ventures, and Lone Star Investment Advisors.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series A, Seed, Series B
  • United States, Israel, Sweden
Portfolio highlights
  • Validic — Meet the only EHR-integrated remote care solution delivering personalized care for clinicians and patients, making personal health data actionable.
  • Prolocor — Our goal is to develop a more precise method and diagnostic tool for assessing and managing risk in cardiovascular disease.
  • Worlds — Worlds is completely re-inventing how organizations see and understand their worlds. Through live, AI-powered models, the company’s clients can remotely see, learn and analyze their worlds in ways that were never possible before.
Global Life Science Ventures VC Fund · München, Bayern, Germany
Global Life Science Ventures (GLSV) was a venture capital fund focusing exclusively on the life sciences. GLSV was dedicated to supporting early-stage groups, originating from universities, scientific institutions or industry. The fund also invested in selected later stage companies, including buy-outs. For this purpose, GLSV provided finance,advice and access to expertise and networks. The group advised and managed funds totaling more than € 200 million. With offices in Germany and Switzerland, GLSV acted as one team with a global perspective. The first fund started its activities in 1996 and invested in 18 companies. The second fund GLSV II started in 2001 and invested in 18 companies primarily in Europe and the US. After termination of the investment period, the fund exited the remaining assets in 2015 and is in liquidation.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series C, Series A, Series B
  • United States, Germany, Denmark
Portfolio highlights
  • Action Pharma — Action Pharma A/S operates as a research and development focused biotechnology company. It discovers and develops new drugs and treatment concepts to treat cardiovascular disease and inflammatory diseases, as well as metabolic diseases, such as type-II diabetes and obesity. The company's product pipeline includes AP214, a modifiedÐMSH-peptide analogue for the treatment of post-surgical kidney injury associated with cardiac surgery; and AP1030 and AP11 series, oral anti-diabetic (OAD) for the treatment of type-II diabetes associated with overweight/obesity. Its product pipeline also comprise AP1189, an oral anti-inflammatory compound for the treatment of inflammatory diseases, such as inflammatory bowel disease and rheumatoid arthritis; and AP405, a modified MSH peptide analogue for the treatment of inflammatory skin diseases, such as atopic dermatitis. The company was founded in 2000 and is based in Holte, Denmark.
  • Coapt Systems — Coapt Systems, Inc. engages in the design, development, manufacture, and marketing of bio-absorbable implants for use in soft tissue fixation during facial cosmetic surgery procedures. It offers ENDOTINE Forehead 3.0, a bioabsorbable brow fixation device; ENDOTINE Forehead Instrument Kits that comprise insertion tools, drill bits, and sterilizationtrays with lids; ENDOTINE Triple 3.0, the bioabsorbable brow fixation devices with disposable drill bits and insertion tools; ENDOTINE TransBleph 3.0, a bioabsorbable upper lid and brow fixation devices. The company also provides ENDOTINE Midface ST 4.5, a bioabsorbable midface suspension devices; ENDOTINE Ribbon, a bioabsorbable fixation devices; Coapt Manual Surgical Drills, the manual surgical hand drills for use with ENDOTINE implants; and SurgiWire Incisionless Dissectors, the subcutaneous The Endotine product line was bought by MicroAire, a surgical device manufacturer in Charlottesville, VA, in August 2010.
  • Santaris Pharma — Spearheading RNA molecule research since 2003, our site in Copenhagen is focused on leading chemistry for targeting any type of transcribed RNA using short synthetic single-strand oligonucleotides. Here, our experts in the field pioneered our core technology platform of locked nucleic acids (LNA) and antisense oligonucleotides (ASO).
Loric Ventures VC Fund · London, England, United Kingdom
Technology is transforming the way we live, work and play. Loric Ventures invests in innovative and disruptive solutions globally, with a focus on fin- and urbantech and impact.
Show more
Investment focus
  • Real Estate, Financial Services, FinTech
  • Seed, Pre-Seed, Series A
  • Germany, United Kingdom, United States
Portfolio highlights
  • SaveIN — SaveIN, as the name suggests, is a financial services platform made exclusively for Indians, with an aim to revolutionize their experience across banking and daily financial transactions.We aim to offer, the full suite of traditional banking products and experiences, but in a never seen before avatar, thereby making it fun, simple, secure, andunbelievably rewarding experience. All this and more at just the click of a button, in a 100% digital and paperless, mobile first ecosystem.
  • SKYSEED — Mit Drohnen und Saatpellets
  • Lun — Your all-in-one heat pump platform. Streamline system design, lead qualification, scheduling, quoting and much more.
KHAN Technology Transfer Fund VC Fund · Dortmund, Nordrhein-Westfalen, Germany
KHAN Technology Transfer Fund operates as an investment firm.
Show more
Investment focus
  • Medical, Therapeutics, Biotechnology
  • Seed, Series A
  • Germany, Czech Republic, United Kingdom
Portfolio highlights
  • Nodus Oncology — Nodus Oncology Developing the DDR targeting therapies.
  • Casinvent Pharma — Casinvent Pharma develops new therapeutic options for the treatment of selected malignancies.
  • Qli5 Therapeutics — Qli5 Therapeutics develops a new class of proteasome inhibitors with high selectivity and unique, non-covalent binding properties.
Saarbruecker 21 VC Fund · Berlin, Berlin, Germany · 3 investments in the past 12 months
They are a group of friends and internet/tech entrepreneurs who first met ten years ago in Saarbruecker Strasse 21 in Berlin Prenzlauer Berg. All of them started successful businesses, they are founders and share a passion for building great companies. As active business angels, they also invest in young startups, either individually orcollectively as a group. They provide seed funding for killer-founders and great ideas. But way more important: they help to avoid mistakes that they have already made . They introduce to the right people. They provide with all the experience that they have. Not just talking about it but helping hands-on.
Show more
Investment focus
  • Software, Internet, E-Commerce
  • Seed, Pre-Seed, Angel
  • Germany, United States, Israel
Portfolio highlights
  • Floy — Floy develops AI-driven software that supports radiologists in detecting complex and hard-to-identify diseases. The collaboration of Floy-AI and radiologists ensures optimal patient outcomes by enabling the early detection and thus early treatment of diseases.One of Floy’s distinguishing features is our innovative incentive structure. We partnerwith radiology offices to jointly offer patients our AI as a “second opinion”. This unique approach motivates radiologists to embrace Floy-AI and encourages widespread adoption.Since its establishment in 2021, Floy secured €8.8 million in funding and rapidly expanded its presence with over 150 radiology locations to date. Floy’s overarching mission is to pioneer proactive medicine by providing exceptional AI-powered diagnostic experiences for health-conscious patients.
  • a2zebra — a2zebra is a zebra company that specializes in instructional technology for elementary school kids.
  • Seqstant — Seqstant offers the LiveGene platform for real-time pathogen analysis, allowing for sensitive, specific, and user-friendly real-time genetic diagnostics.
Investors by industry
Investors by country
VC Funds in Germany by industry